Andre A Kiryanov

This inventor holds 15 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Takeda Pharmaceutical Company Limited, Takeda San Diego, Inc.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andre A Kiryanov. Retrieved from https://idiyas.com/inventor/andre-a-kiryanov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 40.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 101(Granted Patents)

Company Filing History:

14 out of 1,232

Takeda Pharmaceutical Company Limited

patents

1 out of 53

Takeda San Diego, Inc.

patents

Years Active: 2010-2022

Loading Chart...

Areas of Expertise:

PHD Inhibitors

GPR6 Modulators

PARP Inhibitors

Hydroxysteroid Dehydrogenase

Polo-Like Kinase

Renin Inhibitors

Pyrido Compounds

Pyrazol Derivatives

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11426397 - Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 (2022-08-30),

2. 10407409 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD (2019-09-10),

3. 9944626 - 6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD (2018-04-17),

4. 9708296 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD (2017-07-18),

5. 9345713 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD (2016-05-24),

6. 9187497 - Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP) (2015-11-17),

7. 9040522 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD (2015-05-26),

8. 8822470 - Substituted pyrido[2,3-b]pyrazines (2014-09-02),

9. 8541417 - Poly (ADP-ribose) polymerase (PARP) inhibitors (2013-09-24),

10. 8450323 - Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine (2013-05-28),

11. 8318727 - Polo-like kinase inhibitors (2012-11-27),

12. 8138168 - Renin inhibitors (2012-03-20),

13. 8124606 - Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3',2′-e]pyrazin-6(6aH)-ones (2012-02-28),

14. 7928105 - Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones (2011-04-19),

15. 7759339 - Hydroxysteroid dehydrogenase inhibitors (2010-07-20),

Title: The Innovative Journey of Andre A Kiryanov

Introduction: Andre A Kiryanov, a pioneering inventor based in San Diego, CA, is a remarkable woman who has made significant contributions to the field of technology through her inventive spirit and dedication to innovation.

Latest Patents: Andre A Kiryanov holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of interests and expertise in cutting-edge technologies.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Andre A Kiryanov has had a successful career marked by groundbreaking inventions that have pushed the boundaries of what is possible in the tech industry.

Collaborations: Throughout her career, Andre A Kiryanov has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life, demonstrating her ability to work effectively in multidisciplinary teams to achieve innovative results.

Conclusion: Andre A Kiryanov's innovative spirit, coupled with her determination to make a positive impact through her inventions, has solidified her reputation as a trailblazing inventor in the competitive world of technology. Her contributions continue to inspire future generations of inventors to think outside the box and pursue their creative visions relentlessly.

Profile summary based on public USPTO records.